Activation of β-Catenin by Oncogenic PIK3CA and EGFR Promotes Resistance to Glucose Deprivation by Inducing a Strong Antioxidant Response

被引:8
|
作者
Cardone, Luca [1 ]
Bardelli, Alberto [2 ,3 ]
Avvedimento, Vittorio Enrico [1 ]
机构
[1] Univ Naples Federico II, Sch Med, Dept Biol & Cellular & Mol Pathol, Naples, Italy
[2] Univ Turin, Sch Med, Inst Canc Res & Treatment, Mol Genet Lab, Turin, Italy
[3] FIRC Inst Mol Oncol IFOM, Milan, Italy
来源
PLOS ONE | 2012年 / 7卷 / 05期
关键词
GROWTH-FACTOR-RECEPTOR; TUMOR-CELL GROWTH; OXIDATIVE STRESS; PROTEIN-KINASE; BREAST-CANCER; HIGH-FREQUENCY; LUNG-CANCER; METABOLISM; MUTATIONS; GENE;
D O I
10.1371/journal.pone.0037526
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Glucose is an essential fuel for cell survival and its availability limits aberrant cellular proliferation. We have hypothesized that specific cancer mutations regulate metabolic response(s) to glucose deprivation (GD). By means of somatic knock-in cellular models, we have analyzed the response to glucose deprivation in cells carrying the frequent (delE746-A750)EGFR, (G13D)KRAS or (E545K)PIK3CA cancer alleles. We demonstrate that, in mammary epithelial cells, glucose has an essential antioxidant function and that these cells are very sensitive to GD. Conversely, isogenic cells carrying the (delE746-A750)EGFR or the (E545K)PIK3CA, but not the (G13D)KRAS allele, display high tolerance to GD by stimulating the expression of anti-oxidant genes (MnSOD and catalase). This adaptive transcriptional response is mediated by the activation of WNT/beta-catenin and FOXO4 signalling. Our data highlights a new functional synergism between oncogenic EGFR and PIK3CA with WNT/beta-catenin conferring high tolerance to oxidative stress generated by nutrient deprivation.
引用
收藏
页数:13
相关论文
共 12 条
  • [1] Activation of diverse signalling pathways by oncogenic PIK3CA mutations
    Wu, Xinyan
    Renuse, Santosh
    Sahasrabuddhe, Nandini A.
    Zahari, Muhammad Saddiq
    Chaerkady, Raghothama
    Kim, Min-Sik
    Nirujogi, Raja S.
    Mohseni, Morassa
    Kumar, Praveen
    Raju, Rajesh
    Zhong, Jun
    Yang, Jian
    Neiswinger, Johnathan
    Jeong, Jun-Seop
    Newman, Robert
    Powers, Maureen A.
    Somani, Babu Lal
    Gabrielson, Edward
    Sukumar, Saraswati
    Stearns, Vered
    Qian, Jiang
    Zhu, Heng
    Vogelstein, Bert
    Park, Ben Ho
    Pandey, Akhilesh
    NATURE COMMUNICATIONS, 2014, 5
  • [2] Oncogenic activation of PIK3CA in cancers: Emerging targeted therapies in precision oncology
    Wang, Yuxiang
    Rozen, Valery
    Zhao, Yiqing
    Wang, Zhenghe
    GENES & DISEASES, 2025, 12 (02)
  • [3] Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner
    Madsen, Ralitsa R.
    Knox, Rachel G.
    Pearce, Wayne
    Lopez, Saioa
    Mahler-Araujo, Betania
    McGranahan, Nicholas
    Vanhaesebroeck, Bart
    Semple, Robert K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (17) : 8380 - 8389
  • [4] FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration
    Li, Sisi
    Huang, Xiao-ting
    Wang, Meng-yao
    Chen, Dong-ping
    Li, Ming-yi
    Zhu, Yan-yi
    Yu, Yi
    Zheng, Lu
    Qi, Bin
    Liu, Jin-quan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
    Sartore-Bianchi, Andrea
    Martini, Miriam
    Molinari, Francesca
    Veronese, Silvio
    Nichelatti, Michele
    Artale, Salvatore
    Di Nicolantonio, Federica
    Saletti, Piercarlo
    De Dosso, Sara
    Mazzucchelli, Luca
    Frattini, Milo
    Siena, Salvatore
    Bardelli, Alberto
    CANCER RESEARCH, 2009, 69 (05) : 1851 - 1857
  • [6] Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations
    Park, Ye-Lim
    Kim, Hwang-Phill
    Cho, Young-Won
    Min, Dong-Wook
    Cheon, Seul-Ki
    Lim, Yoo Joo
    Song, Sang-Hyun
    Kim, Sung Jin
    Han, Sae-Won
    Park, Kyu Joo
    Kim, Tae-You
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (02) : 389 - 401
  • [7] Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA)
    Burke, John E.
    Perisic, Olga
    Masson, Glenn R.
    Vadas, Oscar
    Williams, Roger L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (38) : 15259 - 15264
  • [8] Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver
    Li, Xiaolei
    Tao, Junyan
    Cigliano, Antonio
    Sini, Marcella
    Calderaro, Julien
    Azoulay, Daniel
    Wang, Chunmei
    Liu, Yan
    Jiang, Lijie
    Evert, Katja
    Demartis, Maria I.
    Ribback, Silvia
    Utpatel, Kirsten
    Dombrowski, Frank
    Evert, Matthias
    Calvisi, Diego F.
    Chen, Xin
    ONCOTARGET, 2015, 6 (12) : 10102 - 10115
  • [9] The Role of PIK3CA Mutations among Lung Adenocarcinoma Patients with Primary and Acquired Resistance to EGFR Tyrosine Kinase Inhibition
    Wu, Shang-Gin
    Chang, Yih-Leong
    Yu, Chong-Jen
    Yang, Pan-Chyr
    Shih, Jin-Yuan
    SCIENTIFIC REPORTS, 2016, 6
  • [10] PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas
    Black, Jonathan D.
    Lopez, Salvatore
    Cocco, Emiliano
    Bellone, Stefania
    Altwerger, Gary
    Schwab, Carlton L.
    English, Diana P.
    Bonazzoli, Elena
    Predolini, Federica
    Ferrari, Francesca
    Ratner, Elena
    Silasi, Dan-Arin
    Azodi, Masoud
    Schwartz, Peter E.
    Santin, Alessandro D.
    BRITISH JOURNAL OF CANCER, 2015, 113 (07) : 1020 - 1026